707 / 1498
What is new?
(compared to 2007)
Staging:
PET/CT for routine
staging
of FDG-avid Lymphomas
BMBx
not required for HL and most DLBCL
Simplification of
Ann Arbor
Response assessment:
PET/CT is standard of care for
remission
assessment
Standard tool for reporting response is 5-PS (
Deauville criteria
)
Deauville Criteria can be used to assign
metabolic response categories
(CMR, PMR, NMR, PMD)
Revised CT
size
criteria
Surveillance:
Routine scanning discouraged.